ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
- PMID: 34807007
- PMCID: PMC8754510
- DOI: 10.14309/ajg.0000000000001538
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Abstract
Gastroesophageal reflux disease (GERD) continues to be among the most common diseases seen by gastroenterologists, surgeons, and primary care physicians. Our understanding of the varied presentations of GERD, enhancements in diagnostic testing, and approach to patient management have evolved. During this time, scrutiny of proton pump inhibitors (PPIs) has increased considerably. Although PPIs remain the medical treatment of choice for GERD, multiple publications have raised questions about adverse events, raising doubts about the safety of long-term use and increasing concern about overprescribing of PPIs. New data regarding the potential for surgical and endoscopic interventions have emerged. In this new document, we provide updated, evidence-based recommendations and practical guidance for the evaluation and management of GERD, including pharmacologic, lifestyle, surgical, and endoscopic management. The Grading of Recommendations, Assessment, Development, and Evaluation system was used to evaluate the evidence and the strength of recommendations. Key concepts and suggestions that as of this writing do not have sufficient evidence to grade are also provided.
Copyright © 2021 by The American College of Gastroenterology.
Figures
Comment in
-
Letter to the Editor in Response to ACG Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease.Am J Gastroenterol. 2022 Dec 1;117(12):2083. doi: 10.14309/ajg.0000000000001967. Am J Gastroenterol. 2022. PMID: 36002917 No abstract available.
Similar articles
-
American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendations.Gastrointest Endosc. 2025 Feb;101(2):267-284. doi: 10.1016/j.gie.2024.10.008. Epub 2024 Dec 17. Gastrointest Endosc. 2025. PMID: 39692638
-
BRAZILIAN CLINICAL GUIDELINE FOR THE THERAPEUTIC MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE (BRAZILIAN FEDERATION OF GASTROENTEROLOGY, FBG).Arq Gastroenterol. 2024 Mar 15;61:e23154. doi: 10.1590/S0004-2803.24612023-154. eCollection 2024. Arq Gastroenterol. 2024. PMID: 38511797 Review.
-
Gastroesophageal reflux: management guidance for the pediatrician.Pediatrics. 2013 May;131(5):e1684-95. doi: 10.1542/peds.2013-0421. Epub 2013 Apr 29. Pediatrics. 2013. PMID: 23629618 Review.
-
Reflux and acid peptic diseases in the elderly.Clin Geriatr Med. 2014 Feb;30(1):29-41. doi: 10.1016/j.cger.2013.10.006. Clin Geriatr Med. 2014. PMID: 24267600 Review.
-
GERD: Diagnosing and treating the burn.Cleve Clin J Med. 2015 Oct;82(10):685-92. doi: 10.3949/ccjm.82a.14138. Cleve Clin J Med. 2015. PMID: 26469826 Review.
Cited by
-
Noninvasive, MultiOmic, and Multicompartmental Biomarkers of Reflux Disease: A Systematic Review.Gastro Hep Adv. 2023;2(4):608-620. doi: 10.1016/j.gastha.2023.01.014. Epub 2023 Jan 21. Gastro Hep Adv. 2023. PMID: 38009162 Free PMC article.
-
Is It Time for Noncontinuous Therapy for Gastroesophageal Reflux Disease?Gastroenterol Hepatol (N Y). 2024 Aug;20(5):273-280. Gastroenterol Hepatol (N Y). 2024. PMID: 39193078 Free PMC article.
-
Complex Gastroesophageal Reflux Disease.Gastro Hep Adv. 2022 Apr 5;1(3):420-430. doi: 10.1016/j.gastha.2022.02.014. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131678 Free PMC article. Review.
-
Enhanced Risk of Gastroesophageal Reflux Disease and Esophageal Complications in the Ulcerative Colitis Population.J Clin Med. 2024 Aug 14;13(16):4783. doi: 10.3390/jcm13164783. J Clin Med. 2024. PMID: 39200925 Free PMC article.
-
Post-reflux swallow-induced peristaltic wave index: a new parameter for the identification of non-acid gastroesophageal reflux-related chronic cough.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666231220819. doi: 10.1177/17534666231220819. Ther Adv Respir Dis. 2024. PMID: 38183263 Free PMC article.
References
-
- Katz PO, Gerson LB, and Vela MF, Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol, 2013. 108(3): p. 308–28; quiz 329. - PubMed
-
- Guyatt G, et al., GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol, 2011. 64(4): p. 383–94. - PubMed
-
- Balshem H, et al., GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol, 2011. 64(4): p. 401–6. - PubMed
-
- Andrews JC, et al., GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol, 2013. 66(7): p. 726–35. - PubMed
-
- Numans ME, et al., Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med, 2004. 140(7): p. 518–27. - PubMed